SCHEMBL20394231

SCHEMBL20394231

COc1ccccc1-c1cccnc1Oc1ccc(CNc2ccccc2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 5/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
CYP1A2 P05177 6/20 0.41
CYP3A4 P08684 6/20 0.41
ALOX15 P16050 6/20 0.41
HSD17B10 Q99714 6/20 0.41
CYP2D6 P10635 5/20 0.41
CYP2C19 P33261 4/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
TSHR P16473 2/20 0.41
TDP1 Q9NUW8 3/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 1/20 0.41
ALOX12 P18054 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ELANE P08246 1/20 0.41
EGFR P00533 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20394304 0.84 GRM5 (0.47) PDE10AALDH1A1TDP1KDM4ESMN1; SMN2
SCHEMBL20394467 0.84 PDE10A (0.47) PDE10AALDH1A1TDP1SMN1; SMN2ELANE
SCHEMBL20394324 0.83 PDE10A (0.48) PDE10AMEN1ALDH1A1KMT2ATDP1
SCHEMBL20406679 0.79 PDE10A (0.48) PDE10AALDH1A1TDP1SMN1; SMN2ELANE
SCHEMBL20755033 0.79 CYP1A2 (0.53) PDE10ACYP1A2CYP3A4ALOX15HSD17B10
SCHEMBL20394409 0.79 PDE10A (0.50) PDE10AALDH1A1TDP1SMN1; SMN2ELANE
SCHEMBL20394414 0.78 PDE10A (0.49) PDE10AALDH1A1ELANE
SCHEMBL20406642 0.77 PDE10A (0.47) PDE10AALDH1A1TDP1SMN1; SMN2ELANE
SCHEMBL20406210 0.77 CYP1A2 (0.43) PDE10ACYP1A2CYP3A4HSD17B10CYP2D6
SCHEMBL20755042 0.77 PDE10A (0.48) PDE10AALDH1A1TDP1SMN1; SMN2ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3351533-B1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMA CO LTD (JP) 2025-07-23 EP disclosed
US-10647675-B2 Biaryl derivative and medicine containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2020-05-12 US disclosed
US-10647675-B2 Biaryl derivative and medicine containing same KAKEN PHARMACEUTICAL CO., LTD. (JP) 2020-05-12 US disclosed
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2019-02-21 US disclosed
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME KAKEN PHARMACEUTICAL CO., LTD. (JP) 2019-02-21 US disclosed
EP-3351533-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME Kaken Pharmaceutical Co., Ltd. (JP) 2018-07-25 EP disclosed
EP-3351533-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME Kaken Pharmaceutical Co., Ltd. (JP) 2018-07-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647675-B2 Biaryl derivative and medicine containing same MAN2B1, CBR3, MANBA PDE10A 4605/4885MAOA 620/4885MAOB 256/4885
US-20190055199-A1 BIARYL DERIVATIVE AND MEDICINE CONTAINING SAME MAN2B1, CBR3, MANBA PDE10A 4605/4885MAOA 620/4885MAOB 256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.